HIV-1 Treatment Optimisation
The NEAT ID Foundation supports clinical research focused on therapeutic strategies for people living with HIV-1, with particular attention to treatment adjustment and regimen performance in complex care settings.
- Antiretroviral therapy
- Treatment switch strategies
- Viral suppression
Its funded studies include evaluation of regimen changes for patients with limited therapeutic options and assessment of outcomes linked to maintaining HIV viral load control.
Advanced HIV Infection
Clinical activity also centres on advanced HIV infection, including patients who present late during acquisition of the virus and require careful optimisation of treatment choices.
- Late presentation
- Therapeutic resistance
- Complex patient management
Research in this area addresses the needs of individuals with advanced disease and limited options for sustained antiretroviral control.
Integrase Inhibitor and Protease Inhibitor Regimens
The sponsor has a clear interest in comparing integrase inhibitor-based regimens with boosted protease inhibitor treatments in people with advanced HIV disease.
- Regimen comparison
- Therapeutic equivalence
- Virologic outcomes
This includes studies examining whether one treatment approach offers improved control or maintains non-inferior outcomes in challenging clinical settings.
Patient-Focused HIV Care
As a patient organisation, the foundation is involved in research addressing real-world treatment needs for people living with HIV, especially those with restricted therapeutic choices.
- Limited therapeutic options
- Switching therapy
- Clinical outcome monitoring
Its trial portfolio spans multiple collaborating sites across several European countries, reflecting interest in specialist HIV care delivery.
